TGF-β receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells

Journal of Cell Biology

Volumn 163, Issue 6, 2003, Pages 1303-1311

  Watabe, Tetsuro ^a   Nishihara, Ayako ^a   Mishima, Koichi ^a   Yamashita, Jun ^b   Shimizu, Kiyoshi ^c   Miyazawa, Keiji ^a   Nishikawa, Shin Ichi ^d   Miyazono, Kohei ^a,e  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KIRIN BREWERY CO LTD   (Japan)

^d RIKEN Center for Biosystems Dynamics Research   (Japan)

^e CANCER INSTITUTE   (Japan)

Author keywords

Claudin 5; Endothelial development; SB 431542; Tight junction; Vascular progenitor cells

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ACTIVIN; CLAUDIN; CLAUDIN 5; PHOSPHOTRANSFERASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL DIFFERENTIATION; CELL GROWTH; EMBRYO CELL; ENDOTHELIUM CELL; ENZYME INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEM CELL; TIGHT JUNCTION; UPREGULATION;

ACTIVINS; ANIMALS; BENZAMIDES; BLOOD VESSELS; CAPILLARY PERMEABILITY; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; DIOXOLES; ENDOTHELIUM, VASCULAR; FETUS; MEMBRANE PROTEINS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PLURIPOTENT STEM CELLS; PROTEIN-SERINE-THREONINE KINASES; STEM CELLS; TIGHT JUNCTIONS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

ANIMALIA;

EID: 0347363474     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200305147     Document Type: Article

References (26)

1. Annes, J.P., J.S. Munger, and D.B. Rifkin. 2003. Making sense of latent TGF-β activation. J. Cell Sci. 116:217-224.
2. Asahara, T., T. Murohara, A. Sullivan, M. Silver, R. van der Zee, T. Li, B. Witzenbichler, G. Schatteman, and J.M. Isner. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275:964-967.
3. Baird, A., and T. Durkin. 1986. Inhibition of endothelial cell proliferation by type β-transforming growth factor: interactions with acidic and basic fibroblast growth factors. Biochem. Biophys. Res. Commun. 138:476-482.
4. Callahan, J.F., J.L. Burgess, J.A. Fornwald, L.M. Gaster, J.D. Harling, F.P. Harrington, J. Heer, C. Kwon, R. Lehr, A. Mathur, et al. 2002. Identification of novel inhibitors of the transforming growth factor beta1 (TGF-β1) type I receptor (ALK5). J. Med. Chem. 45:999-1001.
5. Carmeliet, P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6:389-395.
6. Ema, M., P. Faloon, W.J. Zhang, M. Hirashima, T. Reid, W.L. Stanford, S. Orkin, K. Choi, and J. Rossant. 2003. Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Dev. 17:380-393.
7. Folkman, J., and P.A. D'Amore. 1996. Blood vessel formation: what is its molecular basis? Cell. 87:1153-1155.
8. Goumans, M.J., and C. Mummery. 2000. Functional analysis of the TGF-β receptor/Smad pathway through gene ablation in mice. Int. J. Dev. Biol. 44:253-265.
9. Goumans, M.J., G. Valdimarsdottir, S. Itoh, A. Rosendahl, P. Sideras, and P. ten Dijke. 2002. Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J. 21:1743-1753.
10. Inman, G.J., F.J. Nicolas, J.F. Callahan, J.D. Harling, L.M. Gaster, A.D. Reith, N.J. Laping, and C.S. Hill. 2002. SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62:65-74.
11. Kawabata, M., H. Inoue, A. Hanyu, T. Imamura, and K. Miyazono. 1998. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J. 17:4056-4065.
12. Marchetti, S., C. Gimond, K. Iljin, C. Bourcier, K. Alitalo, J. Pouyssegur, and G. Pages. 2002. Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo. J. Cell Sci. 115:2075-2085.
13. Marchuk, D.A. 1998. Genetic abnormalities in hereditary hemorrhagic telangiectasia. Curr. Opin. Hematol. 5:332-338.
14. Massague, J. 1998. TGF-β signal transduction. Annu. Rev. Biochem. 67:753-791.
15. Morita, K., H. Sasaki, M. Furuse, and S. Tsukita. 1999. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J. Cell Biol. 147:185-194.
16. Nishihara, A., T. Watabe, T. Imamura, and K. Miyazono. 2002. Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension. Mol. Biol. Cell. 13:3055-3063.
17. Nitta, T., M. Hata, S. Gotoh, Y. Seo, H. Sasaki, N. Hashimoto, M. Furuse, and S. Tsukita. 2003. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 161:653-660.
18. Oh, S.P., T. Seki, K.A. Goss, T. Imamura, Y. Yi, P.K. Donahoe, L. Li, K. Miyazono, P. ten Dijke, S. Kim, and E. Li. 2000. Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA. 97:2626-2631.
19. Ota, T., M. Fujii, T. Sugizaki, M. Ishii, K. Miyazawa, H. Aburatani, and K. Miyazono. 2002. Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-β in human umbilical vein endothelial cells. J. Cell. Physiol. 193:299-318.
20. Pollman, M.J., L. Naumovski, and G.H. Gibbons. 1999. Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-β1 in endothelial cells versus smooth muscle cells. Circulation. 99:2019-2026.
21. Risau, W. 1997. Mechanisms of angiogenesis. Nature. 386:671-674.
22. Sata, M., A. Saiura, A. Kunisato, A. Tojo, S. Okada, T. Tokuhisa, H. Hirai, M. Makuuchi, Y. Hirata, and R. Nagai. 2002. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8:403-409.
23. Senger, D.R., S.J. Galli, A.M. Dvorak, C.A. Perruzzi, V.S. Harvey, and H.F. Dvorak. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:983-985.
24. The International PPH Consortium. 2000. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. Nat. Genet. 26:81-84.
25. Tsukita, S., M. Furuse, and M. Itoh. 2001. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol. 2:285-293.
26. Yamashita, J., H. Itoh, M. Hirashima, M. Ogawa, S. Nishikawa, T. Yurugi, M. Naito, and K. Nakao. 2000. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 408:92-96.